Dr. Laurie E Kilpatrick's lab focuses on understanding how different types of immune cells, specifically neutrophils, contribute to sepsis, a life-threatening condition caused by infection. The lab uses innovative techniques like 'organ-on-chip' technology to model human responses and characterize neutrophil behavior, aiming to develop targeted treatments for sepsis based on individual patient profiles. By linking immune cell characteristics to clinical outcomes, the research aims to improve therapies for this critical condition.